Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 March 2006, Vol. 107, No. 5, pp. 1837-1846.
Prepublished online as a Blood First Edition Paper on November 8, 2005; DOI 10.1182/blood-2005-03-1180.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-03-1180v1
107/5/1837    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karpatkin, S.
Right arrow Articles by Gupta, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karpatkin, S.
Right arrow Articles by Gupta, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted March 25, 2005
Accepted August 12, 2005

Hematopoiesis and stem cell renewal in long-term bone marrow cultures containing catalase

Simon Karpatkin*, Ross Basch, and Rashmi Gupta

NYU Cancer Institute, New York University School of Medicine, New York, NY, USA
Department of Medicine, New York University School of Medicine, New York, NY, USA; NYU Cancer Institute, New York University School of Medicine, New York, NY, USA
Department of Pathology, New York University School of Medicine, New York, NY, USA; Department of Medicine, New York University School of Medicine, New York, NY, USA

* Corresponding author; email: simon.karpatkin{at}med.nyu.edu.

Culturing mouse bone marrow in the presence of catalase dramatically alters hematopoiesis. Granulocyte output is initially increased 4-5 fold. This increase is transient and granulocyte production declines as immature (Sca-1+/LIN-) cells accumulate. One-third of these immature cells have a phenotype (Sca-1+/c-Kit +) characteristic of hematopoietic stem cells. At 2-3 weeks there are >200 fold more Sca-1+/c-Kit+/LIN- cells in treated cultures than in controls. This population contains functional stem cells with both short-term and long-term bone marrow repopulating activity. In addition to myeloid progenitors, this Sca-1+/LIN- population contain a large number of cells that express CD31, CD34, and have an active Tie-2 promoter, indicating that they are in the endothelial lineage. After 3-4 weeks hematopoiesis in treated cultures wanes but if catalase is removed, hematopoiesis resumes. After 7-10 days the cultures are indistinguishable from untreated controls. Thus, protected from H2O2, hematopoietic progenitors multiply and become quiescent. This sequence resembles in vivo development in normal marrow. These results make it clear that peroxide-sensitive regulatory mechanisms play an important role in controlling hematopoiesis ex vivo and presumably in vivo as well. They also indicate that manipulation of the peroxide levels can be used to enhance the growth of hematopoietic stem cells in culture.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020